Intron associated with myotonic dystrophy type 2 and methods of use
US6902896B2 · kind B2 · utility
28Cited by
0References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2002 |
| Grant date | Jun 7, 2005 |
| Priority date | — |
| Expiry date | Nov 17, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or are at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.